S. Miyakis et al., DIFFERENTIAL EXPRESSION AND MUTATION OF THE RAS FAMILY GENES IN HUMANBREAST-CANCER, Biochemical and biophysical research communications (Print), 251(2), 1998, pp. 609-612
The expression of ras mRNA levels in 27 human sporadic breast cancer s
pecimens was examined, and compared to the corresponding adjacent norm
al tissue using the RT-PCR technique. Eighteen out of the 27 specimens
(67%) exhibited two- to four-fold increased expression of ras mRNA le
vels, compared to corresponding normal tissue. The rates of augmented
mRNA expression mere similar among the three ras genes. A statisticall
y significant correlation of overexpression of ras genes in specimens
classified as Stage I disease was observed, compared to tumors in a mo
re advanced stage (II or III). The incidence of codon 12 point mutatio
ns of the R-ras gene in fresh tissue samples was also assessed in 61 h
uman sporadic breast cancer cases. Point mutations were detected in fo
ur (6.5%) out of the 61 cases examined; no correlation was found with
any clinicopathological parameter. This is the first report to our kno
wledge of the differential expression of the ras family genes in breas
t carcinoma. Our findings indicate that the aberrant expression of ras
genes may be an initial event in breast cancer oncogenesis and that K
-ras point mutations are rarely involved in the development of mammary
neoplasias. (C) 1998 Academic Press.